2022
DOI: 10.1096/fj.202101333r
|View full text |Cite
|
Sign up to set email alerts
|

Anticancer activity and metabolic profile alterations by ortho‐topolin riboside in in vitro and in vivo models of non‐small cell lung cancer

Abstract: Lung cancer has the highest incidence and mortality rates among all types of cancer worldwide, and 80%-85% of patients with lung cancer are diagnosed with non-small cell lung cancer (NSCLC), which has 5-year survival rate of only 5% at advanced stages. Development of new therapeutic agents and strategies is required to enhance the treatment efficiency in patients with NSCLC. Metabolic alterations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 67 publications
(76 reference statements)
0
2
0
Order By: Relevance
“…Based on the data on the cytoprotective activity of the structurally similar compounds [5,19,22,23], we tested the synthesized compounds in two antioxidant models (protection against the H2O2 and CoCl2 cytotoxicity) in a 24-hour incubation.…”
Section: Cytoprotectionmentioning
confidence: 99%
See 1 more Smart Citation
“…Based on the data on the cytoprotective activity of the structurally similar compounds [5,19,22,23], we tested the synthesized compounds in two antioxidant models (protection against the H2O2 and CoCl2 cytotoxicity) in a 24-hour incubation.…”
Section: Cytoprotectionmentioning
confidence: 99%
“…Plant-isolated compounds [1], such as flavonoids [2][3][4] and phytohormones, as well as their synthetic analogs [5][6][7][8][9] are considered to be very promising as potential anti-cancer agents.…”
Section: Introductionmentioning
confidence: 99%